Search research articles
Contact Us
Filters
Showing results (41-50 of 166) with videos related to
Page
of 17
Sort By:
Journal of Endocrinological Investigation
|
August 1, 1985
Factitious hypermineralocorticoidism due to transdermal application of a 9-alpha-prednisolone containing ointment
R Pedrinelli, A Lucarini, L Graziadei, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 1, 1995
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension
S Taddei, A Virdis, P Mattei, et al.
Journal of Nephrology
|
July 1, 1997
Endothelial function in hypertension
P Mattei, A Virdis, L Ghiadoni, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1992
Nonadrenergic sympathetic vascular control of the human forearm in hypertension: possible involvement of neuropeptide Y
T Kahan, S Taddei, R Pedrinelli, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 21, 2000
Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension
L Ghiadoni, A Virdis, A Magagna, et al.
Circulation
|
September 29, 1999
Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients
S Taddei, L Ghiadoni, A Virdis, et al.
Journal of Nephrology
|
August 6, 2000
Endothelial dysfunction in hypertension
S Taddei, A Virdis, L Ghiadoni, et al.
Archivio Per Le Scienze Mediche
|
April 1, 1971
[Experimental studies of the concentration of hyaluronidase in vaginal secretion of patients with pre-neoplastic and neoplastic lesions of the uterine cervix]
A Panazzolo, P Cacciari, S Scuro, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1986
Verapamil antagonizes forearm vasoconstriction mediated by selective alpha 1- and alpha 2-agonists in hypertensive patients
R Pedrinelli, S Taddei, L Graziadei, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 1, 1997
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension
S Taddei, A Virdis, L Ghiadoni, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 166) with videos related to
Sort By:
Page
of 17
Journal of Endocrinological Investigation
|
August 1, 1985
Factitious hypermineralocorticoidism due to transdermal application of a 9-alpha-prednisolone containing ointment
R Pedrinelli, A Lucarini, L Graziadei, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 1, 1995
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension
S Taddei, A Virdis, P Mattei, et al.
Journal of Nephrology
|
July 1, 1997
Endothelial function in hypertension
P Mattei, A Virdis, L Ghiadoni, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1992
Nonadrenergic sympathetic vascular control of the human forearm in hypertension: possible involvement of neuropeptide Y
T Kahan, S Taddei, R Pedrinelli, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 21, 2000
Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension
L Ghiadoni, A Virdis, A Magagna, et al.
Circulation
|
September 29, 1999
Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients
S Taddei, L Ghiadoni, A Virdis, et al.
Journal of Nephrology
|
August 6, 2000
Endothelial dysfunction in hypertension
S Taddei, A Virdis, L Ghiadoni, et al.
Archivio Per Le Scienze Mediche
|
April 1, 1971
[Experimental studies of the concentration of hyaluronidase in vaginal secretion of patients with pre-neoplastic and neoplastic lesions of the uterine cervix]
A Panazzolo, P Cacciari, S Scuro, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1986
Verapamil antagonizes forearm vasoconstriction mediated by selective alpha 1- and alpha 2-agonists in hypertensive patients
R Pedrinelli, S Taddei, L Graziadei, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 1, 1997
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension
S Taddei, A Virdis, L Ghiadoni, et al.
Page
of 17